To elucidate the molecular mechanisms underlying the impact of LRRK2 G2019S on CAC development, we examined colon tumor tissues from AOM/DSS-treated LRRK2 KI and WT mice to assess the activation of various pro-tumor effectors. This evidence concerns the gene LRRK2 and digestive system neoplasm.